Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Schaffhausenon Aug 28, 2018 9:00pm

89 Views

Post# 28532865

Spontaneous regression of tumour ...role of microbial infect

Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment

Regression of cancer is a very well studied topic. In particular, superficial cancers can be triggered into regression by strong immune response to microbial infection. Surgical and/or invasive procedures carry high risk of introduction of microbes into the body.

TLT scientific commitee needs to address whether or not any of the patients had any signs or symptoms of any infection in the bladder or otherwise after the treatment.

Cheers,

Schaff

Bullboard Posts

The top 10 Canadian medical stocks